Efficacy of Intra-Articular Corticosteroid Injections on Clinical Outcomes in Patients With Operative Distal Radius Fractures

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTeeradon Waewworawit

About this trial

The randomized controlled study which compare clinical outcomes (functional score) in patients with distal radius fractures who underwent open reduction with internal fixation and received intra-articular steroid injections to those who received placebo injections.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age more than 18 years old

Closed unstable distal radius fracture unstable type which need surgical management

Received procedure ORIF with plate and screws at injured wrist

Disqualifiers

History of corticosteroid allergy

Poor Diabetes controlled (HbA1C) > 8

Who need Ritonavir while enter this study

Unable to follow up until the end of projects

Trial design

Design model

Parallel

Treatments tested in this trial

  • Triamcinolone Acetonide

    Drug

    receive intraarticular triamcinolone injection

  • Normal saline

    Drug

    receive intraarticular normal saline injection

Treatment groups

58 Participants
are divided into 2 treatment groups
Group A: Intraarticular triamcinolone injectionExperimental treatment 1 intervention
Group B: placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Patient-Rated Wrist Evaluation Score

(0-100) Higher scores mean poorer functional outcome

Time frame
12 months

Secondary outcomes

1

Visual Analog Scale:

(0-10) Higher scores mean more pain

Time frame
12 months
2

Grip strength (kg)

Measure by hand dynamometer

Time frame
12 months
3

Wrist circumference

Time frame
12 months
4

ROM of wrist

range of motion

Time frame
12 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Teeradon Waewworawit

Lead sponsor

Ramathibodi Hospital

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: